These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 34298056)

  • 1. Revealing the importance of carrier-cargo association in delivery of insulin and lipidated insulin.
    Diedrichsen RG; Harloff-Helleberg S; Werner U; Besenius M; Leberer E; Kristensen M; Nielsen HM
    J Control Release; 2021 Oct; 338():8-21. PubMed ID: 34298056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stereochemistry and Intermolecular Interactions Influence Carrier Peptide-Mediated Insulin Delivery.
    Diedrichsen RG; Tuelung PS; Foderà V; Nielsen HM
    Mol Pharm; 2023 Feb; 20(2):1202-1212. PubMed ID: 36607603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. One-month subchronic toxicity study of cell-penetrating peptides for insulin nasal delivery in rats.
    Khafagy el-S; Kamei N; Nielsen EJ; Nishio R; Takeda-Morishita M
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):736-43. PubMed ID: 24060698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carrier peptide interactions with liposome membranes induce reversible clustering by surface adsorption and shape deformation.
    Diedrichsen RG; Vetri V; Prévost S; Foderà V; Nielsen HM
    J Colloid Interface Sci; 2023 Nov; 650(Pt B):1821-1832. PubMed ID: 37515972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased Carrier Peptide Stability through pH Adjustment Improves Insulin and PTH(1-34) Delivery In Vitro and In Vivo Rather than by Enforced Carrier Peptide-Cargo Complexation.
    Kristensen M; Guldsmed Diedrichsen R; Vetri V; Foderà V; Mørck Nielsen H
    Pharmaceutics; 2020 Oct; 12(10):. PubMed ID: 33092079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of different intestinal conditions on the intermolecular interaction between insulin and cell-penetrating peptide penetratin and on its contribution to stimulation of permeation through intestinal epithelium.
    Kamei N; Aoyama Y; Khafagy el-S; Henmi M; Takeda-Morishita M
    Eur J Pharm Biopharm; 2015 Aug; 94():42-51. PubMed ID: 25960330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Region-Dependent Role of Cell-Penetrating Peptides in Insulin Absorption Across the Rat Small Intestinal Membrane.
    Khafagy el-S; Iwamae R; Kamei N; Takeda-Morishita M
    AAPS J; 2015 Nov; 17(6):1427-37. PubMed ID: 26216471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Penetratin-Mediated Transepithelial Insulin Permeation: Importance of Cationic Residues and pH for Complexation and Permeation.
    Kristensen M; Franzyk H; Klausen MT; Iversen A; Bahnsen JS; Skyggebjerg RB; Foderà V; Nielsen HM
    AAPS J; 2015 Sep; 17(5):1200-9. PubMed ID: 25990963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Applicability and Limitations of Cell-Penetrating Peptides in Noncovalent Mucosal Drug or Carrier Delivery Systems.
    Kamei N; Bech Nielsen EJ; Nakakubo T; Aoyama Y; Rahbek UL; Pedersen BL; Takeda-Morishita M
    J Pharm Sci; 2016 Feb; 105(2):747-753. PubMed ID: 26869427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploration of the Key Factors for Optimizing the in Vivo Oral Delivery of Insulin by Using a Noncovalent Strategy with Cell-Penetrating Peptides.
    Kamei N; Shigei C; Hasegawa R; Takeda-Morishita M
    Biol Pharm Bull; 2018; 41(2):239-246. PubMed ID: 29386483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanistic study of the uptake/permeation of cell-penetrating peptides across a caco-2 monolayer and their stimulatory effect on epithelial insulin transport.
    Kamei N; Onuki Y; Takayama K; Takeda-Morishita M
    J Pharm Sci; 2013 Nov; 102(11):3998-4008. PubMed ID: 23963728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of intestinal luminal contents and the importance of microfold cells on the ability of cell-penetrating peptides to enhance epithelial permeation of insulin.
    Kamei N; Kawano S; Abe R; Hirano S; Ogino H; Tamiwa H; Takeda-Morishita M
    Eur J Pharm Biopharm; 2020 Oct; 155():77-87. PubMed ID: 32781024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular Effects and Delivery Propensity of Penetratin Is Influenced by Conjugation to Parathyroid Hormone Fragment 1-34 in Synergy with pH.
    Kristensen M; Nielsen LH; Zor K; Boisen A; Christensen MV; Berthelsen J; Mørck Nielsen H
    Bioconjug Chem; 2018 Feb; 29(2):371-381. PubMed ID: 29155563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell-Penetrating Peptides as Carriers for Transepithelial Drug Delivery.
    Panou DA; Diedrichsen RG; Kristensen M; Nielsen HM
    Methods Mol Biol; 2022; 2383():371-384. PubMed ID: 34766302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell-Penetrating Peptides as Carriers for Transepithelial Drug Delivery In Vitro.
    Rønholt S; Kristensen M; Nielsen HM
    Methods Mol Biol; 2015; 1324():261-77. PubMed ID: 26202275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Penetratin derivative-based nanocomplexes for enhanced intestinal insulin delivery.
    Zhu X; Shan W; Zhang P; Jin Y; Guan S; Fan T; Yang Y; Zhou Z; Huang Y
    Mol Pharm; 2014 Jan; 11(1):317-28. PubMed ID: 24255985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo proof of concept of oral insulin delivery based on a co-administration strategy with the cell-penetrating peptide penetratin.
    Nielsen EJ; Yoshida S; Kamei N; Iwamae R; Khafagy el-S; Olsen J; Rahbek UL; Pedersen BL; Takayama K; Takeda-Morishita M
    J Control Release; 2014 Sep; 189():19-24. PubMed ID: 24973720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Facilitated nanoscale delivery of insulin across intestinal membrane models.
    Woitiski CB; Sarmento B; Carvalho RA; Neufeld RJ; Veiga F
    Int J Pharm; 2011 Jun; 412(1-2):123-31. PubMed ID: 21501675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PEG-PGA enveloped octaarginine-peptide nanocomplexes: An oral peptide delivery strategy.
    Niu Z; Samaridou E; Jaumain E; Coëne J; Ullio G; Shrestha N; Garcia J; Durán-Lobato M; Tovar S; Santander-Ortega MJ; Lozano MV; Arroyo-Jimenez MM; Ramos-Membrive R; Peñuelas I; Mabondzo A; Préat V; Teixidó M; Giralt E; Alonso MJ
    J Control Release; 2018 Apr; 276():125-139. PubMed ID: 29518466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell-Penetrating Peptides as Carriers for Oral Delivery of Biopharmaceuticals.
    Kristensen M; Nielsen HM
    Basic Clin Pharmacol Toxicol; 2016 Feb; 118(2):99-106. PubMed ID: 26525297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.